Skip to main content
  1. Gene Therapy Development
    • Gene Therapy Development
    What are the key considerations in assessing biodistribution and effective concentration for both kn ...
  2. Gene Therapy Development
    • Gene Therapy Development
    Which are the best strategies to reduce costs while maintaining quality? Which are the advances in p ...
  3. C & G Bioprocessing
    • C & G Bioprocessing
    Process design and improvement. Phase appropriate: process and assay GMP perspective and CDMO/in hou ...
  4. C & G Manufacturing
    • C & G Manufacturing
    Innovative viral vector production: improving efficiency, reducing time, and lowering costs
    • C & G Bioprocessing
    • C & G Manufacturing
    • Cell Therapy Development
    • Gene Therapy Development
    Afternoon Refreshments
    • C & G Bioprocessing
    • C & G Manufacturing
    • Cell Therapy Development
    • Gene Therapy Development
    Morning Refreshments
  5. C & G Manufacturing
    • C & G Manufacturing
    How can manufacturers build an effective potency assurance strategy to guarantee the consistency and ...
    • C & G Bioprocessing
    • C & G Manufacturing
    • Cell Therapy Development
    • Gene Therapy Development
    Evening Drinks Reception
  6. C & G Bioprocessing
    • C & G Bioprocessing
    Sponsor-led Poster Presentation: Comparative Analysis of T-Cell Expansion by Bioreactor Type: Impacts on Process Metrics and Cell Quality

    The device used to manufacture an immunotherapeutic agent is a highly relevant factor in ensuring the most optimal product in terms of the time it takes to produce a dose of the therapy, the risk encountered in processing, and the final quality of that product. Three types of devices for T cell expansion were compared: a static culture perfusion membrane platform (SCPM), a rocking bag device (RB), and two sizes of hollow-fiber perfusion bioreactor (HFB-Large and HFB-Small). The T cell yield, time to dose, fold-expansion (FE), open events (OE), and Hands on Time (HoT) required for each device were measured.

  7. Gene Therapy Development
    • Gene Therapy Development
    Sponsor-Led Poster Presentation: Cell & Gene Bioprocessing topic: Quantification of Single Cell Vector Copy Number in CAR T Cell Products Utilizing a Novel Microfluidic Technology
    CAR-T immuno-therapies have been transformative solutions to treat cancer patients. As most CAR-T th ...
    • C & G Bioprocessing
    • C & G Manufacturing
    • Cell Therapy Development
    • Gene Therapy Development
    1-2-1 Meetings / Networking Break
    • C & G Bioprocessing
    • C & G Manufacturing
    • Cell Therapy Development
    • Gene Therapy Development
    Spotlight Presentation: Elevate AAV manufacturing: tailored cell lines for purity and sustainability
    Engineered cell lines have the potential to transform the landscape of AAV production. Stable cell l ...
    • C & G Bioprocessing
    • C & G Manufacturing
    • Cell Therapy Development
    • Gene Therapy Development
    1-2-1 Meetings / Networking Break
    • C & G Bioprocessing
    • C & G Manufacturing
    • Cell Therapy Development
    • Gene Therapy Development
    Networking Lunch
  8. Gene Therapy Development
    • Gene Therapy Development
    Are we doing enough? Exploring biosafety challenges in cell and gene therapies
  9. Cell Therapy Development
    • Cell Therapy Development
    Expansion into Non-Oncology Indications: The Critical Role of CDMO Partners
    What are the key drivers behind the growing interest in non-oncological gene therapies and Which non ...
    • C & G Bioprocessing
    • C & G Manufacturing
    • Cell Therapy Development
    • Gene Therapy Development
    1-2-1 Meetings / Networking Break
    • C & G Bioprocessing
    • C & G Manufacturing
    • Cell Therapy Development
    • Gene Therapy Development
    1-2-1 Meetings / Networking Break
  10. C & G Manufacturing
    • C & G Manufacturing
    How can manufacturers develop an effective potency assurance strategy to guarantee the consistency a ...
  11. C & G Bioprocessing
    • C & G Bioprocessing
    How can early process designs evaluate scalability and incorporate technology to support growing dem ...
  12. Cell Therapy Development
    • Cell Therapy Development
    How to develop stealth mechanisms to enhance the persistence of allogeneic therapies, including iPSC ...
    • C & G Bioprocessing
    • C & G Manufacturing
    • Cell Therapy Development
    • Gene Therapy Development
    Opening Address & Keynote Presentation: Potency assay technical transfer best practice
    Potency assays measure the biological activity of biological products, providing data on drug dose, ...
    • C & G Bioprocessing
    • C & G Manufacturing
    • Cell Therapy Development
    • Gene Therapy Development
    Registration